搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
2 小时
Can Taking Antidepressants Cause Weight Loss?
If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...
1 天
NHS warns Brits on antidepressants to avoid this one fruit
The NHS specifically warns patients taking selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline ...
来自MSN
1 天
Weighing in on weight gain from antidepressants
If you’re struggling with depression, the most important question about taking an antidepressant is whether it will work. But ...
22 小时
Can Lexapro Cause Weight Loss? What to Know
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
Healthline
2 天
Which Antidepressant Is Considered Safest While Breastfeeding?
The selective serotonin reuptake inhibitor sertraline is often among the preferred antidepressants to take when breastfeeding ...
Healthline
6 天
Can Antidepressants Help You Sleep?
Yes, some antidepressants can help you sleep. This is because many antidepressants have sedative properties, which may improve sleep efficiency and reduce the amount of times you wake up during ...
The i on MSN
6 天
Five unanswered questions about antidepressants and depression
Whether antidepressants are a good option for relieving depression is in the spotlight again, in a new book, Chemically ...
HealthDay on MSN
6 小时
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...
mic
1 天
A Nasal Spray For Depression? FDA Gives Its Approval
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...
1 天
The FDA just approved this ketamine-derived nasal spray for depression treatment
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
NJBIZ
19 小时
J&J’s ketamine-based drug approved as standalone treatment
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
The American Journal of Managed Care
1 天
Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression
Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈